血糖水平对18F-FDG PET标准化摄取值影响的系统评价与荟萃分析
该研究基于29项研究、8380例患者的20,807个SUV测量数据,分析扫描前血糖水平与SUVmax和SUVmean的相关性。结果显示血糖升高与脑和肌肉SUV降低、肝和血池SUV升高显著相关,而肿瘤SUV无显著相关;仅血糖>200 mg/dl组的肿瘤SUVmax显著降低。作者认为血糖低于200 mg/dl时无需干预降糖,除非肝脏为感兴趣器官。
要点
- 血糖升高与脑和肌肉SUVmax及SUVmean降低显著相关,与肝和血池SUV升高显著相关。
- 血糖与肿瘤SUVmax或SUVmean无显著相关性;仅血糖>200 mg/dl组肿瘤SUVmax显著降低。
- 血糖低于200 mg/dl时无需干预降糖,除非肝脏为感兴趣器官。
核心结论
- 血糖低于200 mg/dl时无需干预降低血糖,除非肝脏为感兴趣器官。
- 未来需研究评估高血糖状态下FDG-PET诊断恶性病灶的敏感性和特异性。
研究设计与样本
- 文献检索MEDLINE、Embase和Cochrane图书馆数据库。
- 对个体数据进行多因素回归分析,调整性别、年龄、BMI、糖尿病诊断、18F-FDG注射剂量和时间间隔。
- 采用ANOVA检验比较五组血糖水平(<110、110-125、125-150、150-200和>200 mg/dl)间SUVmax或SUVmean的差异。
- 纳入29项研究、8380例患者,共20,807个SUVmax和SUVmean测量数据。
主要发现
- 血糖升高与脑SUVmax降低(p<0.001)和SUVmean降低(p<0.001)显著相关。
- 血糖升高与肌肉SUVmax降低(p<0.001)和SUVmean降低(p<0.001)显著相关。
- 血糖升高与血池SUVmax升高(p=0.008)和SUVmean升高(p<0.001)显著相关。
- 血糖与肿瘤SUVmax或SUVmean无显著相关性;ANOVA中仅血糖>200 mg/dl组肿瘤SUVmax显著降低。
关键数值与推荐
- 血糖分组:<110、110-125、125-150、150-200和>200 mg/dl。
- ANOVA显示所有高血糖组脑和肌肉SUV显著低于血糖正常组,肝和血池SUV显著高于血糖正常组。
临床怎么用
- 血糖低于200 mg/dl时无需干预降糖,除非肝脏为感兴趣器官。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the effect of pre-scan blood glucose levels (BGL) on standardized uptake value (SUV) in 18F-FDG-PET scan. METHODS: A literature review was performed in the MEDLINE, Embase, and Cochrane library databases. Multivariate regression analysis was performed on individual datum to investigate the correlation of BGL with SUVmax and SUVmean adjusting for sex, age, body mass index (BMI), diabetes mellitus diagnosis, 18F-FDG injected dose, and time interval. The ANOVA test was done to evaluate differences in SUVmax or SUVmean among five different BGL groups (< 110, 110-125, 125-150, 150-200, and > 200 mg/dl). RESULTS: Individual data for a total of 20,807 SUVmax and SUVmean measurements from 29 studies with 8380 patients was included in the analysis. Increased BGL is significantly correlated with decreased SUVmax and SUVmean in brain (p < 0.001, p < 0.001,) and muscle (p < 0.001, p < 0.001) and increased SUVmax and SUVmean in liver (p = 0.001, p = 0004) and blood pool (p = 0.008, p < 0.001). No significant correlation was found between BGL and SUVmax or SUVmean in tumors. In the ANOVA test, all hyperglycemic groups had significantly lower SUVs compared with the euglycemic group in brain and muscle, and significantly higher SUVs in liver and blood pool. However, in tumors only the hyperglycemic group with BGL of > 200 mg/dl had significantly lower SUVmax. CONCLUSION: If BGL is lower than 200 mg/dl no interventions are needed for lowering BGL, unless the liver is the organ of interest. Future studies are needed to evaluate sensitivity and specificity of FDG-PET scan in diagnosis of malignant lesions in hyperglycemia.
引用
- Eskian M, Alavi A, Khorasanizadeh M, et al. Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements. Eur J Nucl Med Mol Imaging. 2018. PMID: 30350009. doi:10.1007/s00259-018-4194-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。